|
CBD Clinical Trials
3 actively recruiting trials across 1 location
Also known as: AVCN319301a, Epidiolex
Pipeline
Phase 2: 2
Top Sponsors
- University Health Network, Toronto1
- Sunnybrook Health Sciences Centre1
- Massachusetts General Hospital1
Indications
- Osteoarthritis of Knee1
- Osteoarthritis, Hip1
- Alzheimer's Disease1
- Back Pain1
- Depressive Symptoms1
Other2 trials
Boston, Massachusetts1 trial
Cannabidiol for Reduction of Brain Neuroinflammation
Massachusetts General Hospital
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.